Position in SLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,599,282
+$8,091,850 QoQ
Shares Held
1,329,625
+7.7% QoQ
Ownership
2.14%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#5
of 72 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLN Over Time
Shares Held
Position Value (USD)
Derivatives in SLN
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$59,551
PutShares
11,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. SLN ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in SLN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,599,282 | 1,329,625 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $59,551 | 11,300 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $6,507,432 | 1,234,807 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $89,984 | 14,800 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $1,483,890 | 244,061 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $111,610 | 21,505 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $7,332 | 2,600 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $176,083 | 62,441 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $3,666 | 1,300 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $34,400 | 5,000 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $1,945,230 | 282,737 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $3,440 | 500 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $36,360 | 2,000 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $5,454 | 300 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $7,939,150 | 436,697 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,218,440 | 116,760 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $921,930 | 42,682 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $377,571 | 21,737 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $229,309 | 22,851 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $135,575 | 11,441 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||